InsidersTradesSigma
Follow the Sino Biopharmaceutical Ltd. share price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Sino Biopharmaceutical Ltd. has logged 6 reports. Market capitalisation: €91.5bn. The latest transaction was disclosed on 30 April 2026 (Purchase). Among the most active insiders: Cheng Cheung Ling. All data is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€8m
6 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Sino Biopharmaceutical Ltd. Strong Buy (bullish), based on 20 analysts. Average price target: HK$8.28.
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,657 of 29,062 companies
61.6
score / 100
Value53
Quality70
FCF yld7.4%
Earn yld2.3%
EV/EBITDA14.1x
ROE14%
Gross mgn82%
Net mgn7.4%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 April 2026
Declarations6 total
1,000,000 shares@ HK$5.4410.0059% mcap20.0% of flowShareXHKGHKEX:DA20260430E00374
1,000,000 shares@ HK$5.47050.0060% mcap20.2% of flowShareXHKGHKEX:DA20260429E00338
3,000,000 shares@ HK$5.42820.018% mcap59.9% of flowShareXHKGHKEX:DA20260428E00209
1,748,000 shares@ HK$5.730.0012% mcap100.0% of flowShareXHKGHKEX:DA20260330E00223
6 of 6 declarations
About Sino Biopharmaceutical Ltd.
Sino Biopharmaceutical Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products in China. It primarily focuses on drugs for the treatment of liver diseases and cardiovascular diseases.